191 related articles for article (PubMed ID: 18510248)
1. [Progress of research on pathogenesis and medical treatment of diabetic retinopathy].
Geng S; Ye JJ
Zhonghua Yan Ke Za Zhi; 2008 Jan; 44(1):76-81. PubMed ID: 18510248
[TBL] [Abstract][Full Text] [Related]
2. Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis.
Gardiner TA; Archer DB; Curtis TM; Stitt AW
Microcirculation; 2007 Jan; 14(1):25-38. PubMed ID: 17365659
[TBL] [Abstract][Full Text] [Related]
3. A new view of diabetic retinopathy: a neurodegenerative disease of the eye.
Barber AJ
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):283-90. PubMed ID: 12657367
[TBL] [Abstract][Full Text] [Related]
4. Prospects for angiotensin receptor blockers in diabetic retinopathy.
Sjølie AK
Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627
[TBL] [Abstract][Full Text] [Related]
5. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.
Pruneau D; Bélichard P; Sahel JA; Combal JP
Curr Opin Investig Drugs; 2010 May; 11(5):507-14. PubMed ID: 20419596
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy.
Klein BE; Klein R; McBride PE; Cruickshanks KJ; Palta M; Knudtson MD; Moss SE; Reinke JO
Arch Intern Med; 2004 Sep; 164(17):1917-24. PubMed ID: 15451768
[TBL] [Abstract][Full Text] [Related]
7. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
Adamiec J; Oficjalska-Młyńczak J
Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
[TBL] [Abstract][Full Text] [Related]
8. Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.
Silva PS; Sun JK; Aiello LP
Semin Ophthalmol; 2009; 24(2):93-9. PubMed ID: 19373693
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological approach to diabetic retinopathy.
De La Cruz JP; González-Correa JA; Guerrero A; de la Cuesta FS
Diabetes Metab Res Rev; 2004; 20(2):91-113. PubMed ID: 15037985
[TBL] [Abstract][Full Text] [Related]
10. Potential utility of statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in diabetic retinopathy.
Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
Med Hypotheses; 2006; 66(5):1019-21. PubMed ID: 16188392
[TBL] [Abstract][Full Text] [Related]
11. Could diabetic retinopathy be an autoimmune disease?
Kastelan S; Zjacić-Rotkvić V; Kastelan Z
Med Hypotheses; 2007; 68(5):1016-8. PubMed ID: 17125935
[TBL] [Abstract][Full Text] [Related]
12. [Drug therapy regimens in diabetic retinopathy].
Mitulescu D; Selaru D; Ocian R
Oftalmologia; 1999; 46(1):63-6. PubMed ID: 10641089
[TBL] [Abstract][Full Text] [Related]
13. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological treatment of diabetic retinopathy.
Lang GE
Ophthalmologica; 2007; 221(2):112-7. PubMed ID: 17380065
[TBL] [Abstract][Full Text] [Related]
15. Treating diabetic retinopathy by tackling growth factor pathways.
Chiarelli F; Giannini C; Di Marzio D; Mohn A
Curr Opin Investig Drugs; 2005 Apr; 6(4):395-409. PubMed ID: 15898347
[TBL] [Abstract][Full Text] [Related]
16. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
Kristinsson JK
Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
[TBL] [Abstract][Full Text] [Related]
17. [Occurrence of changes in the eye in diabetic retinopathy with significant myopia].
Dujić M; Misailović K; Nikolić Lj; Ignjacev M
Srp Arh Celok Lek; 1998; 126(11-12):457-60. PubMed ID: 9921019
[TBL] [Abstract][Full Text] [Related]
18. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
Cheung N; Wang JJ; Klein R; Couper DJ; Sharrett AR; Wong TY
Diabetes Care; 2007 Jul; 30(7):1742-6. PubMed ID: 17389333
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of protein kinase C might be harmful to diabetic retinopathy.
Yamagishi S; Takeuchi M
Med Hypotheses; 2004; 63(1):135-7. PubMed ID: 15193366
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of topical administration of brimonidine to reduce ischaemia in the very early stage of diabetic retinopathy in good controlled type-2 diabetes mellitus.
Mondal LK; Baidya KP; Bhattacharya B; Chatterjee PR; Bhaduri G
J Indian Med Assoc; 2004 Dec; 102(12):724-5, 729. PubMed ID: 15871360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
